Evidence map›Paper›PMID 32435531›Full record

ArticlePeerJ2020

Discordance of vancomycin minimum inhibitory concentration for methicillin-resistant Staphylococcus aureus at 2

Chien-Feng Kuo, Chon Fu Lio, Hsiang-Ting Chen, Yu-Ting Tina Wang, Kevin Sheng-Kai Ma, Yi Ting Chou, Fu-Chieh Chang, Shin-Yi Tsai

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Chien-Feng Kuo *Division of Infectious Disease, Mackay Memorial Hospital, Taipei, Taiwan.
Chon Fu Lio *Department of Laboratory Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Hsiang-Ting ChenDivision of Infectious Disease, Mackay Memorial Hospital, Taipei, Taiwan.
Yu-Ting Tina WangDepartment of Laboratory Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Kevin Sheng-Kai MaDepartment of Laboratory Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Yi Ting ChouDepartment of Laboratory Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Fu-Chieh ChangInfection control center, Mackay Memorial Hospital, Taipei, Taiwan.
Shin-Yi TsaiDepartment of Laboratory Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Mackay Memorial Hospital · TWUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVancomycin, the first line antibiotic for methicillin-resistant

methodsIn total, 229 MRSA isolates from blood cultures collected between 2009 and 2015 at a tertiary hospital in Taiwan were examined. The MICs of vancomycin were measured using Vitek 2,

resultsThe geometric mean of the MICs of hospital-acquired MRSA was higher than that of community-acquired MRSA (

conclusionThe Infectious Diseases Society of America recommends the use of alternative antimicrobial agents when vancomycin MIC is ≥ 2 µg/mL; in this study, only 53.6% of the isolates tested using Vitek 2 showed a high MIC in the broth microdilution method. Accurate identification of the resistance profile is a key component of antimicrobial stewardship programs. Therefore, to reduce inappropriate antibiotic use and mitigate the emergence of resistant strains, we recommend using complementary tests such as STRENGTHS: (1) We compared the categorical agreement between different methods measuring MRSA MICs level. (2) Physicians should incorporate this information and consider a complementary test to verify the appropriateness of the decision of shifting vancomycin to second-line antibiotic treatment to improve patients' prognosis. (3) MRSA-vancomycin MICs at a cutoff of 2 µg/mL obtained using Vitek II exhibited a higher sensitivity level and negative predictive value than those obtained using LIMITATION: (1) Our research was based on a single hospital-based study. (2) The MRSA strains in this study were stored for more than 12 months after isolation. (3) We did not collect information on clinical prognosis.

Indexed as

Antimicrobial stewardshipBroth MicrodilutionClinical and Laboratory Standards Institute (CLSI)Community-acquired MRSAE-testHospital-acquired MRSAMethicillin-resistant Staphylococcus aureus (MRSA)Microbial automatic identification system (Vitek II)Minimal inhibitory concentration (MIC )The inter-test agreements

Identifiers

PMID32435531
PMCPMC7224226
OpenAlexW3025174319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.